Compound atlas
Anti-aging

FOXO4-DRI

Also known as · FOXO4

Peptide
Half-life
1h
approx. mean t½
Dose range
5–10 mg / cycle
typical, not prescriptive
Category
Anti-aging
primary use-case
Single-dose decay
t½ = 1h · first-order model
~4h
to clear
1× t½
50%
remaining
2× t½
25%
remaining
~4× t½
6%
remaining
0%25%50%75%100%0m1.2h2.4h3.6h4.8h6h

How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.

Overview

A senolytic peptide studied for selectively clearing senescent ('zombie') cells in animal models.

Mechanism of action

Disrupts the FOXO4–p53 interaction in senescent cells, triggering their apoptosis while sparing healthy cells.

Typical protocol

Pulsed cycles in research settings; human data are absent.

Storage

Reconstituted: refrigerated; protect from light.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.